Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort.
Daniel GuinartHeidi TaipaleJose M RubioAntti TanskanenChristoph U CorrellJari TiihonenJohn M KanePublished in: Schizophrenia bulletin (2022)
NMS remains a potentially life-threatening risk, yet these results should further contribute to mitigate concerns about LAI safety regarding NMS onset or outcomes, including mortality.